KP415.E01: "A Multicenter, Dose-optimized, double-blind, randomized, placebo-controlled, parallel efficacy laboratory classroom study with KP415 in children with attention-deficit/hyperactivity disorder"
Administered By
Awarded By
Contributors
- Dew, Rachel E Principal Investigator
Start/End
- November 7, 2017 - October 1, 2019